J&J Stock Sinks After Revenue Misses and Full-year Outlook Was Cut, as Drug Sales Disappoint
Jason Ware, Partner & Chief Investment Officer at Albion Financial Group, talks about the growth prospects for the healthcare industry and highlights areas in the market that are undervalued.
More Videos
Starbucks Introduces AI Barista: A Glimpse Into the Future of Coffee Service
Starbucks’ AI barista aims to speed service and improve experience. Nick Lichtenberg, Fortune Business Editor, explains its impact on workers and customers.
Tesla & Big Tech’s Earnings Test: Can Massive AI Bets Finally Deliver Revenue Growth?
As Big Tech reports Q3 earnings, investors await proof that massive AI and cloud investments from Meta, Apple, Microsoft, and Alphabet are driving real growth.
How Brain.fm Is Using Sound Science to Rewire Your Mind for Focus and Flow
Brain.fm merges music and neuroscience to enhance focus, creativity, and mental health—Dr. Kevin Woods reveals how sound is transforming cognitive performance.
This Mexican-American Cocktail Bar Has Just Been Named The Best Bar In The USA
An exclusive look inside New York City's Superbueno with founder "Nacho" Jimenez, who's Mexican-American concept has just been named the best bar in the country
Eric Trump on Bitcoin's Future: Inside American Bitcoin’s Strategy for Digital Dominance
Eric Trump joins us to discuss American Bitcoin’s mission, market strategy, and why he believes the U.S. must lead the next era of digital currency innovation.
From Trick to Trend: Unreal Snacks CEO on Why Dye-Free Candy Is Taking Over
Unreal Snacks CEO Kevin McCarthy shares how dye-free candy is leading the sweets revolution—just in time for what could be a record-breaking Halloween 2025.
